Concepedia

Armel Stockis

AS

69

Publications

3.3K

Citations

33

H-Index

1985

Active since

Affiliations

UCB Pharma (Belgium)(Current)

UCB Pharma (United States)

Chiesi (France)

Ziekenhuisnetwerk Antwerpen Stuivenberg

Armel Stockis is an author at UCB Pharma (Belgium) specializing in pharmacotherapy, medicine, and pharmacology.

ORCID

Top concepts

Publications per year

1985–2022

69

Publications

69

Levetiracetam Intravenous Infusion: A Randomized, Placebo‐controlled Safety and Pharmacokinetic Study

Steven Ramael, Agnès Daoust, Christian Otoul et al. · Epilepsia · 2006 · 191 citations · Full text

Nitazoxanide: pharmacokinetics and metabolism in man

J. Broekhuysen, Armel Stockis, R. Lins et al. · International Journal of Clinical Pharmacology and Therapeutics · 2000 · 172 citations

Brivaracetam, a selective high‐affinity synaptic vesicle protein 2A (<scp>SV</scp>2A) ligand with preclinical evidence of high brain permeability and fast onset of action

Jean‐Marie Nicolas, Jonas Hannestad, Daniel Holden et al. · Epilepsia · 2015 · 159 citations · Full text

The pharmacokinetics of oxybutynin in man

J. Douchamps, F. Derenne, Armel Stockis et al. · European Journal of Clinical Pharmacology · 1988 · 138 citations

, , +2

The pharmacokinetics, CNS pharmacodynamics and adverse event profile of brivaracetam after single increasing oral doses in healthy males

Maria Laura Sargentini‐Maier, Paul Rolan, John Connell et al. · British Journal of Clinical Pharmacology · 2007 · 135 citations · Full text

Rows per page

1–5 of 69